|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study
Sung Gu Kang, Eu Chang Hwang, Seung Il Jung, Ho Song Yu, Ho Seok Chung, Taek Won Kang, Dong Deuk Kwon, Jun Eul Hwang, Jun Seok Kim, Joon Hwa Noh, Jae Hyung You, Myung Ki Kim, Tae Hoon Oh, Ill Young Seo, Seung Baik, Chul-Sung Kim, Seok Ho Kang, Jun Cheon
Cancer Res Treat.
2016;48(4):1293-1301. Published online March 23, 2016 DOI:
https://doi.org/10.4143/crt.2016.021
Web of Science 8
Crossref 7
Conditional Survival and Associated Prognostic Factors in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Retrospective Study at a Single Institution
Minyong Kang, Hyung Suk Kim, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
Cancer Res Treat.
2016;48(2):621-631. Published online September 9, 2015 DOI:
https://doi.org/10.4143/crt.2015.220
Web of Science 9
Crossref 9
CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder
Transitional Cell Carcinoma
s
Tae Jung Jang
Cancer Res Treat.
2012;44(4):262-266. Published online December 31, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.4.262
Crossref 2
Results of Additional BCG Therapy for Recurrent
Transitional Cell Carcinoma
after Complete Response to Initial BCG Therapy
H S Ha, C H Park, C I Kim
J Korean Cancer Assoc.
2000;32(2):367-373.
Usefulness of MIB1 Expression as a Prognostic Factor in
Transitional Cell Carcinoma
of Urinary Bladder
Han Kyeum Kim, Young Sik Kim, In Sun Kim
J Korean Cancer Assoc.
1995;27(3):459-468.
Methotrexate , Vinblastine , Doxorubicin and Cisplatin
Jin Soo Chung, Hyeon Hoe Kim, Chong Wook Lee
J Korean Cancer Assoc.
1994;26(4):618-626.
1
Journal Impact Factor 4.6